Cardlytics (CDLX) Tops Q4 EPS by 47c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- US stock futures gain ahead of July inflation data
- Oil rises after attacks on ships in Hormuz, Bab el-Mandeb
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Cardlytics (CDLX) PT Lowered to $3 at Evercore ISI
March 13, 2025 10:02 AM EDTEvercore ISI analyst Mark Mahaney lowered the price target on Cardlytics (NASDAQ: CDLX) to $3.00 (from $4.00) while maintaining a In Line rating.
The analyst comments "Our View: We maintain our In Line rating but lower our price target to $3 (from $4... More
Cardlytics (CDLX) PT Lowered to $2.50 at BofA Securities
March 13, 2025 6:50 AM EDTBofA Securities analyst Omar Dessouky lowered the price target on Cardlytics (NASDAQ: CDLX) to $2.50 (from $4.00) while maintaining a Underperform rating.
The analyst comments "4Q Revenue/Adj. Contribution ($74mn/$41mn) both landed above the high end of guidance ($67mn/$36mn), with EBITDA also... More
